Actonel 150mg Tablet Dosepak

Manufacturer ACTAVIS Active Ingredient Risedronate Tablets(ris ED roe nate) Pronunciation ris ED roe nate
It is used to treat Paget's disease.It is used to prevent or treat soft, brittle bones (osteoporosis).
đŸˇī¸
Drug Class
Bisphosphonate, Agent for osteoporosis
đŸ§Ŧ
Pharmacologic Class
Pyridinyl bisphosphonate, Bone resorption inhibitor
🤰
Pregnancy Category
Category C
✅
FDA Approved
Sep 1998
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Risedronate is a medication used to strengthen bones and prevent fractures, especially in people with osteoporosis. It works by slowing down the natural process of bone breakdown in your body, allowing your bones to become denser and stronger.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions exactly.

Take your medication with plain water only. Avoid taking it with mineral water, milk, or other beverages.
Swallow the medication whole. Do not chew, break, or crush it. Also, do not suck on the medication.
Continue taking your medication as directed by your doctor or healthcare provider, even if you start feeling well.
Take your medication with a full glass of water.
Take it at least 30 minutes before consuming your first food, drink, or other medications of the day.
After taking your medication, do not lie down for at least 30 minutes and wait until you have eaten your first meal of the day before lying down.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place. Avoid storing it in a bathroom.
Keep all medications in a safe location, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist or healthcare provider. If you have questions about disposing of your medication, consult your pharmacist. You may also have access to drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, do not take it later in the same day.
Take the missed dose the next morning as soon as you remember, and then return to your regular schedule.
Do not take two doses on the same day.
* If you are unsure about what to do if you miss a dose, contact your doctor for guidance.
💡

Lifestyle & Tips

  • Take the tablet with a full glass (6-8 ounces) of plain water only (no other liquids).
  • Take the tablet at least 30-60 minutes before your first food, drink, or other medication of the day.
  • Remain in an upright position (sitting or standing) for at least 30-60 minutes after taking the tablet and until after your first food of the day.
  • Do not lie down after taking the tablet.
  • Do not chew or suck on the tablet.
  • Ensure adequate intake of calcium and vitamin D through diet or supplements as advised by your doctor.
  • Maintain good oral hygiene and inform your dentist that you are taking a bisphosphonate.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 150 mg orally once a month (for postmenopausal osteoporosis treatment/prevention)
Dose Range: 150 - 150 mg

Condition-Specific Dosing:

Postmenopausal Osteoporosis (Treatment and Prevention): 150 mg orally once a month
Osteoporosis in Men: Not typically 150mg monthly, usually 35mg weekly or 5mg daily
Glucocorticoid-Induced Osteoporosis: Not typically 150mg monthly, usually 35mg weekly or 5mg daily
Paget's Disease of Bone: Not typically 150mg monthly, usually 30mg daily for 2 months
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dose adjustment needed (CrCl â‰Ĩ 30 mL/min)
Moderate: No dose adjustment needed (CrCl â‰Ĩ 30 mL/min)
Severe: Contraindicated (CrCl < 30 mL/min)
Dialysis: Contraindicated

Hepatic Impairment:

Mild: No dose adjustment needed
Moderate: No dose adjustment needed
Severe: No dose adjustment needed

Pharmacology

đŸ”Ŧ

Mechanism of Action

Risedronate is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption. It binds to hydroxyapatite crystals in bone and inhibits the activity of osteoclasts, thereby decreasing the rate of bone turnover and increasing bone mineral density.
📊

Pharmacokinetics

Absorption:

Bioavailability: <1% (oral, fasting state)
Tmax: Approximately 1 hour
FoodEffect: Food, beverages (other than plain water), and medications (e.g., antacids, calcium supplements) significantly decrease absorption. Bioavailability is reduced by approximately 55% when taken with food.

Distribution:

Vd: Approximately 6.3 L/kg (steady state)
ProteinBinding: Approximately 24%
CnssPenetration: Limited

Elimination:

HalfLife: Terminal half-life: Approximately 480 hours (due to slow release from bone)
Clearance: Renal clearance: Approximately 100 mL/min (for unchanged drug)
ExcretionRoute: Renal (primarily unchanged drug)
Unchanged: Approximately 60-70% of absorbed dose excreted unchanged in urine
âąī¸

Pharmacodynamics

OnsetOfAction: Bone resorption markers decrease within days to weeks; BMD increases typically within 3-6 months.
PeakEffect: Maximal suppression of bone turnover markers typically seen within 3-6 months.
DurationOfAction: Effects on bone mineral density and fracture risk persist as long as treatment continues; residual effects on bone turnover may last for months after discontinuation due to bone binding.

Safety & Warnings

âš ī¸

Side Effects

Serious Side Effects: Seek Medical Attention Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low calcium levels, including:
+ Muscle cramps or spasms
+ Numbness and tingling
+ Seizures
Signs of high blood pressure, such as:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Black, tarry, or bloody stools
Chest pain
Coughing up blood
Vomiting blood or material that looks like coffee grounds
Heartburn
Difficulty swallowing
Severe pain when swallowing
Sore throat
New or unusual pain in the groin, hip, or thigh area
Changes in eyesight, eye pain, or severe eye irritation
Trouble urinating
Pain while urinating

Jawbone Problems

This medication may increase the risk of jawbone problems, especially with long-term use or in people with certain medical conditions, such as cancer, dental problems, or blood clotting disorders. Other factors that may increase the risk include ill-fitting dentures, anemia, infection, dental work, chemotherapy, radiation, or taking other medications that may cause jawbone problems. If you have any of these conditions or concerns, discuss them with your doctor. If you experience jaw swelling or pain, contact your doctor immediately.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild ones. However, if you notice any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor or seek medical help:

Constipation
Diarrhea
Stomach pain
Upset stomach
Vomiting
Bone, joint, or muscle pain
Feeling dizzy, tired, or weak
Headache
Flu-like symptoms

Reporting Side Effects

If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Chest pain, difficulty swallowing, or painful swallowing (signs of esophageal irritation)
  • New or worsening heartburn
  • Severe jaw pain, numbness, or swelling (signs of osteonecrosis of the jaw)
  • New or unusual pain in your thigh, hip, or groin (signs of an atypical femur fracture)
  • Muscle cramps, numbness or tingling (signs of low calcium)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
Certain health conditions, including:
+ Esophageal problems
+ Difficulty swallowing
+ Low calcium levels
+ Kidney disease
If you are unable to stand or sit upright for at least 30 minutes
If you are taking any of the following medications:
+ Cimetidine
+ Dexlansoprazole
+ Esomeprazole
+ Famotidine
+ Lansoprazole
+ Nizatidine
+ Omeprazole
+ Pantoprazole
+ Rabeprazole
+ Ranitidine
* If you are taking another medication that contains the same active ingredient as this drug

Please note that this is not an exhaustive list of all potential interactions. It is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist to ensure safe use. Never start, stop, or adjust the dosage of any medication without consulting your doctor first.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

This drug can cause severe esophageal problems, such as irritation, swelling, ulcers, and bleeding. It is crucial to discuss these potential risks with your doctor.

If you have asthma, be aware that this medication may worsen your condition. Consult your doctor to discuss any concerns.

There is an increased risk of fractures, particularly in the legs, associated with this medication. Talk to your doctor about this potential risk.

Regular blood tests and bone density checks are necessary while taking this medication, as directed by your doctor.

This medication may interfere with certain laboratory tests. Inform all your healthcare providers and laboratory personnel that you are taking this drug.

To maximize the effectiveness of this medication, it is recommended to use it in conjunction with calcium and vitamin D supplements, as well as engage in weight-bearing exercises, such as walking or physical therapy.

Before starting this medication, schedule a dental exam to ensure your teeth and gums are healthy. Practice good oral hygiene and visit your dentist regularly for check-ups.

If you consume alcohol, discuss this with your doctor to understand any potential risks.

Smoking may also impact your health while taking this medication; consult your doctor for guidance.

A severe skin reaction, known as Stevens-Johnson syndrome or toxic epidermal necrolysis, can occur with this medication. This condition can cause severe health problems, potentially leading to death. Seek immediate medical attention if you experience symptoms such as red, swollen, blistered, or peeling skin (with or without fever), red or irritated eyes, or sores in your mouth, throat, nose, or eyes.

If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor. It is necessary to discuss the benefits and risks of this medication to both you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Hypocalcemia (low blood calcium)
  • Hypophosphatemia (low blood phosphate)
  • Upper gastrointestinal adverse reactions (e.g., upset stomach, heartburn, esophagitis)

What to Do:

Administer milk or antacids to bind risedronate. Seek immediate medical attention or call a poison control center (e.g., 1-800-222-1222).

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Patients with hypocalcemia (must be corrected prior to initiation)
  • Patients with severe renal impairment (CrCl < 30 mL/min)
  • Patients with abnormalities of the esophagus which delay esophageal emptying (e.g., stricture or achalasia)
  • Inability to stand or sit upright for at least 30-60 minutes
🔴

Major Interactions

  • Calcium supplements, antacids, iron, magnesium-containing products (significantly reduce absorption of risedronate if taken concurrently or within 30-60 minutes)
  • Aspirin/NSAIDs (potential for increased gastrointestinal irritation)
🟡

Moderate Interactions

  • H2 blockers, proton pump inhibitors (may increase gastric pH, potentially affecting absorption, though less critical than calcium/antacids)
  • Other agents affecting bone metabolism (e.g., corticosteroids, loop diuretics, calcitonin, vitamin D analogs) - monitor calcium levels
đŸŸĸ

Minor Interactions

  • Not many specific minor interactions beyond general GI irritants.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Serum Calcium

Rationale: To ensure normocalcemia before initiation, as hypocalcemia must be corrected.

Timing: Prior to first dose

Serum 25-hydroxyvitamin D

Rationale: To ensure adequate vitamin D levels, as deficiency can impair treatment efficacy and increase hypocalcemia risk.

Timing: Prior to first dose

Renal Function (Serum Creatinine, CrCl)

Rationale: To assess kidney function and ensure CrCl is not below 30 mL/min (contraindication).

Timing: Prior to first dose

Dental Examination

Rationale: Recommended for patients with risk factors for osteonecrosis of the jaw (ONJ) prior to starting bisphosphonate therapy.

Timing: Prior to first dose (especially if risk factors present)

📊

Routine Monitoring

Serum Calcium

Frequency: Periodically, or if symptoms of hypocalcemia occur

Target: 8.5-10.2 mg/dL

Action Threshold: < 8.5 mg/dL (investigate and correct)

Renal Function (Serum Creatinine)

Frequency: Periodically, especially in elderly or those with changing renal status

Target: Within normal limits for age/sex

Action Threshold: CrCl < 30 mL/min (discontinue)

Bone Mineral Density (BMD)

Frequency: Every 1-2 years (DEXA scan)

Target: Improvement or stabilization of T-score

Action Threshold: Significant decline in BMD or new fractures (re-evaluate therapy)

đŸ‘ī¸

Symptom Monitoring

  • Dysphagia (difficulty swallowing)
  • Odynophagia (painful swallowing)
  • Retrosternal pain (chest pain behind the breastbone)
  • New or worsening heartburn (signs of esophageal irritation/ulceration)
  • Jaw pain, swelling, numbness, or heaviness (signs of osteonecrosis of the jaw - ONJ)
  • Unusual pain in the thigh, hip, or groin (signs of atypical femur fracture)

Special Patient Groups

🤰

Pregnancy

Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Risedronate should be used during pregnancy only if the potential benefit justifies the potential risk to the mother and fetus.

Trimester-Specific Risks:

First Trimester: Animal studies show adverse effects on fetal development at high doses. Human data are limited.
Second Trimester: Bisphosphonates are incorporated into the bone matrix and gradually released over weeks to years. The amount incorporated into maternal bone is directly related to the dose and duration of bisphosphonate use. There is a theoretical risk of fetal harm (e.g., hypocalcemia, skeletal abnormalities) due to prolonged exposure.
Third Trimester: Theoretical risk of fetal hypocalcemia and skeletal abnormalities due to prolonged exposure and potential interference with fetal bone mineralization.
🤱

Lactation

It is not known whether risedronate is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from bisphosphonates, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: Risk unknown; theoretical risk of adverse effects on infant bone and calcium metabolism.
đŸ‘ļ

Pediatric Use

Safety and effectiveness in pediatric patients have not been established. Use is not recommended.

👴

Geriatric Use

No overall differences in efficacy or safety have been observed between elderly and younger patients. No dose adjustment is necessary based on age alone, but renal function should be monitored as it commonly declines with age.

Clinical Information

💎

Clinical Pearls

  • Strict adherence to the dosing instructions (taking with plain water, remaining upright, taking on an empty stomach) is critical to minimize the risk of esophageal adverse events.
  • Ensure patients have adequate calcium and vitamin D intake, as these are essential for bone health and bisphosphonate efficacy.
  • A dental examination is recommended prior to initiating risedronate, especially for patients with risk factors for osteonecrosis of the jaw (ONJ).
  • Patients should be advised to report any new or unusual pain in the thigh, hip, or groin, as this could be a symptom of an atypical femur fracture.
  • Consider a 'drug holiday' after 3-5 years of treatment for patients at low-to-moderate fracture risk, as long-term use may increase the risk of atypical femur fractures and ONJ, while benefits may persist.
🔄

Alternative Therapies

  • Other oral bisphosphonates (e.g., alendronate, ibandronate)
  • Intravenous bisphosphonates (e.g., zoledronic acid)
  • Denosumab (Prolia)
  • Teriparatide (Forteo)
  • Abaloparatide (Tymlos)
  • Romosozumab (Evenity)
  • Selective Estrogen Receptor Modulators (SERMs) (e.g., raloxifene)
  • Calcitonin (less effective, generally for pain management in Paget's)
💰

Cost & Coverage

Average Cost: Highly variable, typically $100-$300+ per 150mg tablet (monthly dose)
Generic Available: Yes
Insurance Coverage: Generics are typically Tier 1 or 2. Brand name may be Tier 3 or higher, or require prior authorization.
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure your safety, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which is a valuable resource that provides important information. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, we encourage you to discuss them with your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the overdose, including the amount taken and the time it occurred.